by Laura Smith | May 13, 2022 | Communications, Weekly Cannabis News
May 6th – May 13th 2022 Cannabis to Treat Hyperemesis Gravidarum (HG): Responses from 550 Participants Responses showed that cannabis was more effective than antiemetics in relieving HG-associated symptoms. Pregnancy is a very specific and complex period in a woman’s...by Laura Smith | May 6, 2022 | Communications, Weekly Cannabis News
April 29th – May 6th 2022 Cannabis Use Disorder (CUD) & Development of Limb Ischemia A recent study suggests that individuals with CUD have a higher incidence of clinical admission for acute limb ischemia (ALI). With the increasing number of US states legalizing...by Laura Smith | Apr 29, 2022 | Communications, Weekly Cannabis News
April 22nd – April 29th 2022 Insomnia and Cannabis Use in Individuals with Depression and Anxiety Cannabis was shown to improve sleep behavior in both the depression and anxiety groups, a new study reports. Sleep is a naturally recurring state of mind and body that...by Laura Smith | Apr 25, 2022 | Communications, Weekly Cannabis News
April 15th – April 22nd 2022 Cannabis and Pets: Clinical Outcomes Results from North American Veterinarians Cannabis poisoning in pets have increased since legalization, with the most common route of ingestion attributed to edibles. Along with the increasing number of...by Laura Smith | Apr 22, 2022 | Communications, Weekly Cannabis News
April 8th – April 15th 2022 Perceptions of Risks and Benefits Following Cannabis Use Among the Adolescent and Young Adult Population Ever cannabis users generally report lower risks and greater benefits compared to never users, a new study suggests. Cannabis is known...by Laura Smith | Apr 8, 2022 | Communications, Weekly Cannabis News
April 1st – April 8th 2022 Effects of ∆9-Tetrahydrocannabinol (∆9-THC) and Cannabidiol (CBD) on Blood Viscosity, Elasticity, and Membrane Integrity Caution should be taken when consuming cannabis products in individuals with red blood cells (RBC) disorders, a new...